152 results on '"Amadid, Hanan"'
Search Results
2. Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes in the PIONEER REAL Netherlands Multicentre, Prospective, Observational Study
3. Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes: The PIONEER REAL Switzerland Multicentre, Prospective, Observational Study
4. Glycaemic control, risk of hypoglycaemia and all-cause mortality in new users of second-generation basal insulin with type 2 diabetes and chronic kidney disease: a nationwide register-based cohort study
5. Predicting the HbA1c level following glucose-lowering interventions in individuals with HbA1c-defined prediabetes: a post-hoc analysis from the randomized controlled PRE-D trial
6. PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real‐world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan
7. Time trends of cardiovascular risk management in type 1 diabetes - nationwide analyses of real-life data
8. Use of once‐daily oral semaglutide and associated clinical outcomes among adults with type 2 diabetes in routine clinical practice in Canada: A multicentre, prospective real‐world study (PIONEER REAL Canada)
9. Design and Methodology of the PRIMETIME1 Cohort Study: Precision Medicine Based on Renal Tissue Molecular Interrogation in Diabetic Nephropathy: PUB096
10. The effects of dapagliflozin, metformin or exercise on glycaemic variability in overweight or obese individuals with prediabetes (the PRE-D Trial): a multi-arm, randomised, controlled trial
11. Declining incidence rates of distal symmetric polyneuropathy in persons with type 1 and type 2 diabetes in Denmark, with indications of distinct patterns in type 1 diabetes.
12. Declining Incidence Rates of Distal Symmetric Polyneuropathy in People With Type 1 and Type 2 Diabetes in Denmark, With Indications of Distinct Patterns in Type 1 Diabetes
13. Glucagon-like peptide-1 receptor agonist use is associated with lower blood ferritin levels in people with type 2 diabetes and hemochromatosis: a nationwide register-based study
14. Predicting the HbA1c level following glucose-lowering interventions in individuals with HbA1c-defined prediabetes:a post-hoc analysis from the randomized controlled PRE-D trial
15. Declining Incidence Rates of Distal Symmetric Polyneuropathy in People With Type 1 and Type 2 Diabetes in Denmark, With Indications of Distinct Patterns in Type 1 Diabetes
16. Time Trends in the Incidence of Diabetic Ketoacidosis Leading to Hospital Admission Among Adults With Type 1 Diabetes:A Nationwide Danish Register Study
17. Time Trends in the Incidence of Diabetic Ketoacidosis Leading to Hospital Admission Among Adults With Type 1 Diabetes: A Nationwide Danish Register Study.
18. Predicting the HbA1c level following glucose-lowering interventions in individuals with HbA1c-defined prediabetes: a post-hoc analysis from the randomized controlled PRE-D trial.
19. Physical Activity Dimensions Associated with Impaired Glucose Metabolism
20. The role of physical activity in the development of first cardiovascular disease event: a tree-structured survival analysis of the Danish ADDITION-PRO cohort
21. Predicting the HbA1clevel following glucose-lowering interventions in individuals with HbA1c-defined prediabetes: a post-hoc analysis from the randomized controlled PRE-D trial
22. The process of health behaviour change following participation in a randomised controlled trial targeting prediabetes:A qualitative study
23. 1156-P: Ischaemic Heart Disease in Type 2 Diabetes Before and After Diagnosis: Impact on Expected Lifetime and Trends 1996–2020
24. Additional file 3 of Time trends of cardiovascular risk management in type 1 diabetes - nationwide analyses of real-life data
25. Additional file 2 of Time trends of cardiovascular risk management in type 1 diabetes - nationwide analyses of real-life data
26. Additional file 1 of Time trends of cardiovascular risk management in type 1 diabetes - nationwide analyses of real-life data
27. Additional file 4 of Time trends of cardiovascular risk management in type 1 diabetes - nationwide analyses of real-life data
28. The process of health behaviour changes following participation in a randomised controlled trial targeting prediabetes: A qualitative study
29. Discordance Between Glucose Levels Measured in Interstitial Fluid vs in Venous Plasma After Oral Glucose Administration: A Post-Hoc Analysis From the Randomised Controlled PRE-D Trial
30. Endothelial glycocalyx and cardio-renal risk factors in type 1 diabetes
31. A large remaining potential in lipid‐lowering drug treatment in the type 2 diabetes population: A Danish nationwide cohort study
32. Endothelial glycocalyx and cardio-renal risk factors in type 1 diabetes
33. No effects of dapagliflozin, metformin or exercise on plasma glucagon concentrations in individuals with prediabetes:A post hoc analysis from the randomized controlled PRE-D trial
34. Discordance Between Glucose Levels Measured in Interstitial Fluid vs in Venous Plasma After Oral Glucose Administration:A Post-Hoc Analysis From the Randomised Controlled PRE-D Trial
35. The effects of dapagliflozin, metformin or exercise on glycaemic variability in overweight or obese individuals with prediabetes (the PRE-D Trial):a multi-arm, randomised, controlled trial
36. 380-P: Endothelial Glycocalyx Dimensions and Cardiovascular Risk Factors in Type 1 Diabetes
37. The process of health behaviour change following participation in a randomised controlled trial targeting prediabetes: A qualitative study.
38. SGLT2-hæmmere til type 1-diabetes
39. Timing and frequency of daily energy intake in adults with prediabetes and overweight or obesity and their associations with body fat
40. No effects of dapagliflozin, metformin or exercise on plasma glucagon concentrations in individuals with prediabetes: A post hoc analysis from the randomized controlled PRE‐D trial
41. Timing and Frequency of Daily Energy Intake in Adults with Prediabetes and Overweight or Obesity and Their Associations with Body Fat
42. The effects of dapagliflozin, metformin or exercise on glycaemic variability in overweight or obese individuals with prediabetes (the PRE-D Trial): a multi-arm, randomised, controlled trial
43. 844-P: Effects of Dapagliflozin, Metformin, or Exercise on Plasma Glucagon Concentrations in Individuals with Prediabetes: The PRE-D Trial
44. 137-OR: Trends in Lipid Levels Relative to Lipid-Lowering Drug Use among Danish Type 2 Diabetes Subjects
45. 1491-P: Migrant Disparities in Atherosclerotic Cardiovascular Complications among Persons with Type 2 Diabetes
46. 845-P: Changes in Plasma Levels of Liver Enzymes in Response to Dapagliflozin, Metformin, or Exercise in People with Prediabetes: The PRE-D Trial
47. 105-OR: Trends in Complications in Type 1 and Type 2 Diabetes in Denmark, 1996-2016
48. Habitual physical activity is associated with lower fasting and greater glucose-induced GLP-1 response in men
49. Habitual activity associates with lower fasting and greater glucose-induced GLP-1 response in men
50. MOESM2 of The role of physical activity in the development of first cardiovascular disease event: a tree-structured survival analysis of the Danish ADDITION-PRO cohort
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.